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The  murine  major  histocompatability  (H-2)  antigens  are  polymorphic  cell 
surface glycoproteins that play a  critical role in the interaction of many T  cells 
with their target cells (1). The H-2 antigens are present on nearly all cell types 
of the mouse but are differentially expressed depending on the species of mouse 
studied and the tissue examined (2, 3). For example, mice of the H-2  b haplotype 
express more  H-2D antigen  on  their  cell surfaces than  H-2K.  Similarly,  H-2  a 
haplotype mice express more H-2K on the surface of their cells than  H-2D or 
H-2L, and more H-2D than H-2L. Understanding the mechanisms that regulate 
the amount of H-2 antigen on the cell surface may be important  to our under- 
standing  of  the  control  of  the  immune  system,  as  well  as  the  mechanisms 
controlling cell surface glycoprotein synthesis. 
Each H-2 antigen gene consists of seven or eight exons (see Fig. 1) (4). We and 
others  (5-7)  have cloned  the  genes encoding  the  H-2L  a and  H-2D  d antigens. 
The cloned genes contain all the recognition signals required for the expression 
of the  H-2 antigens,  since mouse  L  cells transfected with  these genes express 
functional H-2D  a and H-2L  d antigens on their cell surface (5, 7-9). The ability 
to  modify  H-2  genes  in  vitro,  reintroduce  them  into  L  cells,  and  study  the 
expression of the" H-2 antigens has proven useful for identifying the features of 
H-2 genes (10,  11). 
We have used just such an assay to examine how the expression of H-2D  a and 
H-2L  a genes could be altered when the normal  H-2 promoters were replaced 
with an exogenous promoter,  the  metallothionein  gene promoter (12).  L  cells 
transfected with such hybrid genes express normal  H-2D  a and  H-2L  a antigens 
on their cell surface but do not express both antigens at the same level. That is, 
H-2D  a antigen expression is two to fourfold higher than H-2L  d antigen expres- 
sion, analogous to the different amounts of the two antigens on the surface of 
H-2  d cells.  Molecular  analyses  of L  cells  transfected  with  these  hybrid  genes 
indicated that the amount of exogenous H-2 antigen expressed on the cell surface 
is independent of the amount of H-2-specific mRNA and H-2-specific cytoplasmic 
protein in the cells (12). Thus, there must be a region of the H-2D  a protein that 
enhances its surface expression relative to H-2L  a antigen, presumably during the 
maturation of the protein after translation. To determine if such a region exists, 
we examined the expression levels of H-2 antigens in which the H-2L  a and H- 
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2D  a domains  were  exchanged.  We  determined  that  the  H-2D  d  N  domain  en- 
hances expression of the H-2D  d antigen. 
Materials and  Methods 
Plasmid Constructions.  The metallothionein-promoted H-2 genes,  DM  and  LM, are 
H-2D  d and H-2L  a, respectively, in which the normal H-2 promoters have been replaced 
with the metallothionein gene promoter (12). Mouse L cells transfected with these hybrid 
genes express functional H-2D  a and H-2L  a antigens on the cell surface. In addition, these 
cells contain 20-60 times the normal amount of H-2 mRNA and the saturating amount 
of H-2 antigen that may be placed on the cell surface (12). 
Hybrid genes formed by exchanging segments of the  H-2L  a and  H-2D  a genes have 
been described elsewhere (10). The plasmids pG24 and pG18 that encode these hybrid 
genes are diagrammed in  Fig.  1, top.  Additionally,  the metallothionein gene-promoted 
hybrid gene, pDL, which contains all exons of the H-2L  a gene except the N domain (see 
Fig. 2, top), has been previously described (11). 
Hybrid genes between the DM and LM plasmids were made by digesting these plasmids 
to completion with BamH1, isolating the two DNA fragments generated by each plasmid, 
and  ligating  the  larger  fragment  from one  plasmid  with  the  smaller  from the  other 
plasmid,  and  vice  versa.  The  correct  orientation  of the  inserts  was  determined  by 
restriction mapping. Manipulation of DNA fragments is described in Maniatis et al. (13). 
Cell Culture, Transfection, and Radioimmunoassay.  Mouse L cells (Tk-) were maintained 
in  Dulbecco's minimum essential  medium (DMEM) ~ supplemented  with  10%  fetal calf 
serum. After transfection, cells were selected for the presence of the exogenously added 
herpes simplex virus thymidine kinase gene (HSV TK) by selection in HAT (hypoxanthine, 
aminopterin, thymidine) media (14). 
Cells were transfected as previously described (5,  12).  Briefly, 5 #g of plasmid DNA 
was mixed with  500  ng HSV TK and 30 #g of C3H carrier DNA and precipitated on 
mouse L cells by calcium phosphate precipitation. After 48 h in nonselective media, cells 
were selected in HAT media. Colonies were picked 3 wk later and analyzed for expression 
of the transfected H-2 antigens by radioimmunoassay using monoclonal antibodies specific 
for the different H-2 antigens (15,  16). 
The presence and  amount of the  transfected and  endogenous  H-2 antigens on  the 
surface of transfected and normal L cells was determined by an indirect radioimmunoassay 
as previously described (12,  17).  Specifically, the appropriate cell cultures were lightly 
trypsinized and washed, and suspended cells counted. Aliquots of the cells were added to 
1 ml  DMEM  and  centrifuged.  The  cell pellets were resuspended  in  50  #1  of a  1:100 
dilution of the appropriate antibody (15, 16) and incubated at 4 °C for 4 h. The cells were 
then washed twice and the pellets resuspended in 50 #1 of ~SI-protein A (New England 
Nuclear, Boston, MA). After incubating  12 h at 4°C, the cells were washed three times 
and  counted  in  a  gamma counter  (LKB  Instruments,  Inc.,  Gaithersburg,  MD).  Each 
antibody was previously titrated against a constant cell number to insure saturation of the 
cells with antibody. Background binding of the  ~SI-protein A was determined by incu- 
bating control  L  cells (untransfected) with the specific antibodies.  These backgrounds, 
usually <500 cpm, were subtracted from the specific binding of the transfected L cells. 
Northern Blot Analysis.  Total cellular RNA was isolated from the appropriate cell lines 
as described (18). Equal amounts of RNA were denatured, electrophoresed in a formal- 
dehyde-agarose  gel,  and  transferred  to  nitrocellulose  as  described  (19).  H-2-specific 
mRNA was detected by hybridization with a s~P-labeled probe that cross-reacted with the 
H-2D  d, H-2L  d, H-2K  k, and H-2D  k transcripts. 
Results 
Previously  (12),  we  have  demonstrated  that,  when  the  H-2L  d  and  H-2D  d 
antigen  genes  are  placed  under  the  control  of  mouse  metallothionein  gene 
1  Abbreviations used in this paper:  DMEM, Dulbecco's minimum essential medium; HAT, hypo- 
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promoter, normal H-2 antigens are expressed on the surface of transfected cells. 
However, the levels of H-2 antigens  expressed are not equal since the amount 
of H-2D  d antigen  on the cell surface is two- to fourfold,  more than  that of H- 
2L  d antigen.  Induction of the metailothionein gene promoter increases the level 
of H-2-specific mRNA (and H-2-specific protein) in the transfected cells several 
fold,  but  not  alter  the  level  of surface  expression  of H-2  antigens  (12).  This 
indicates that the amount of H-2 mRNA made from the metailothionein  gene- 
promoted hybrid genes saturated the transfected cells for the expression of H-2 
antigens.  Thus,  the amount of H-2D  d and H-2L  d on the surface of uninduced, 
transfected DM and LM cells, respectively, was the highest that could be achieved. 
Both DM and LM cells were saturated for the expression of H-2 antigens, and 
this saturation  was clearly posttranslational;  yet the H-2D  d antigen  was present 
on the cell surface in greater quantities  than  the H-2L  d antigen.  We therefore 
expected that  hybrid genes containing  portions of both the  H-2D  d and  H-2L  d 
genes should determine which protein  domains caused enhanced expression of 
H-2D  '~  over  H-2L  d antigen.  Initially,  we  examined  cells  transfected  with  H-2 
genes in which the first three exons had been switched from H-2D  d to H-2L  d, 
and vice versa (Fig.  1, top) (10). The cell lines compared were those transfected 
with  metaliothionein-promoted  H-2D  d (DM-1) (12),  metallothionein-promoted 
H-2L  d (LM-1) (12),  H-2-promoted H-2D/L gene (pG24:37.2.1)  (10), and  H-2- 
promoted  H-2L/D  gene  (pG18:37.1.3)  (10).  Quantitative  radioimmunoassay 
analysis of the amounts of the normal or hybrid H-2 antigens on the surface of 
transfected cells indicated that the first three exons of H-2D  d antigen gene cause 
the enhanced expression of H-2D  a antigen (Fig. 1, bottom). Monocional antibodies 
specific for the C2 domains of the H-2 antigens were used (10); however, other 
monoclonal antibodies specific for H-2D  d and  H-2L  a antigens demonstrate  the 
same level of expression (12 and data not shown). The  37.1.3  and  37.2.1  cells 
showed depressed levels of endogenous H-2 antigens (H-2K  k and H-2D  k) (indic- 
ative of high levels of expression of the transfected H-2 genes; 12), and the H-2- 
specific mRNA levels in the transfected cells were both elevated equally over the 
amount seen in  the  L  cell controls (data not shown).  However, because of the 
possibility of promoter  differences,  we  repeated  these  experiments  with  new 
hybrid genes  in  which  the  normal  H-2  promoter  had  been  replaced  with  the 
metallothionein  gene promoter. 
To eliminate the possibility that the different amounts of hybrid H-2 antigens 
expressed on the surface of 37.2.1 and 37.1.3 cells was due to subtle differences 
in H-2D  d and H-2L  a gene promoters, we prepared H-2 hybrid molecules identical 
to  those  described  above except  that  the  H-2  promoter  was replaced  by the 
metallothionein  gene promoter  (Fig.  2,  top).  Transfection  of these  metallothi- 
onein-promoted hybrid H-2 genes into mouse L cells resulted in cell clones that 
stably expressed and  maintained  the  MDL gene  but not its reciprocal  (MLD). 
The reciprocal MLD gene contains the metallothionein gene promoter followed 
by the L, N, and C1  domains of the H-2L  d gene and the C2, M, I1,  I2, and I3 
domains of the H-2D  d gene. Cell clones expressing the hybrid H-2 gene encoded 
by the  MLD  gene  were  originally  isolated  but  were  unstable  in  culture  and 
quickly  lost  the  ability  to  express  the  hybrid  gene  (data  not  shown).  We also 
examined the cell surface expression levels of a previously described (11) metal- vA  •  un  n  nil  DM-I 
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FIGURE  1.  Radioimmunoassay of transfected mouse L cells expressing hybrid H-2 antigens. 
(Top) Diagram of the hybrid H-2 genes.  The  DM-1  and LM-1  genes are H-2D  d and H-2L  d 
genes, respectively, in which the normal H-2 promoters have been replaced with the metallo- 
thionein gene promoter (12). The 37.2.1 and 37.1.3 constructs represent previously described 
hybrid genes (10) in which the last five coding blocks of the H-2D  d gene have been replaced 
with the analogous sequences from the H-2L  d gene (37.2.1)and vice versa (37.1.3). The black 
areas represent  H-2D  d domains and the stippled areas represent H-2L  d domains.  Diagonal 
lines represent the metatlothionein promoter in place of the H-2 promoter. (Bottom)  Radioim- 
munoassay L cell clones transfected with genes described above. Monoclonal antibodies used 
in this assay were 34.2.12 (specific for the C2 domain of H-2D  ~ molecule) (3'2A) for the DM- 
1 and 37.1.3 cell lines, and 28.14.8 (specific for the C2 domain of the H-2L  a molecule) (3,2a) 
for the LM-1 and 37.2.1 cell lines (10). 
Iothionein gene-promoted hybrid H-2 gene (pDL), in which only the N domain 
of the H-2L  a gene had been replaced by the N domain of the H-2D  d molecule 
(Fig. 2, top). 
To determine the levels of normal and hybrid H-2 antigens expressed on the 
surface of transfected L  cells, a  quantitative radioimmunoassy was performed 
using an H-2D  d C2-specific monoclonal antibody, for the DM-1 cell, and an H- 
2L  d C2-specific monoclonal antibody for the LM-1, MDL, and pDL transfected 
cells (Fig. 2, bottom). Again the expression of hybrid H-2 antigen containing the 
first three domains of the H-2D  d molecule (MDL) was identical to that of the 
normal H-2D  d antigen produced from the metallothionein-promoted H-2D  d gene 
(DM-1).  Also,  the  metallothionein  gene-promoted  hybrid  H-2  antigen  that 360  DIFFERENTIAL  EXPRESSION OF  H-2D  d AND  H-2L  d ANTIGENS 
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FIGURE 2.  Construction and expression of metallothionein-promoted H-2 hybrid molecules. 
(Top) Diagram of hybrid  molecules MDL and  pDL  constructed  from  the  DM  and  LM 
metallothionein-promoted H-2 molecules. (Bottom) Radioimmunoassay of the DM-I-, LM-I-, 
pDL-, and MDL-transfected L cells. Expression of the foreign H-2 antigens was determined 
using H-2D  d- and H-2Ld-specific  monoclonal antibodies (see Fig. 1). 
contained only the  N  domain of the H-2D  'l gene was expressed on the surface 
of the  transfected  L  cells at  a  level  identical  to  that  seen  for  H-2D  d antigen 
expressed on the surface of DM-1. 
Although all H-2 genes analyzed in Fig. 2 contained the metallothionein gene 
promoter and were therefore under the same transcriptional control, these cells 
do  not  contain  the  same  number  of transfected  H-2  genes  (data  not  shown). 
Thus,  the level of H-2-specific mRNA  in the recipient cells may vary with the 
copy number of the transfected gene.  Previously (12), we have shown that the 
variability of copy number  inherent  in  DNA  transfections does not appear  to 
influence  the  cell  surface  expression  of  H-2  antigens  transcribed  under  the 
control of the metallothionein gene promoter, since the mouse L cells are easily 
saturated for cell surface expression of new H-2 antigens, presumably due to a 
limitation  of/3~-microglobulin (12).  However, to insure  that  the  LM-1,  DM-1, 
MDL,  and  pDL  cells  were  making  comparable  levels  of metaliothionein-pro- 
moted,  H-2-specific  mRNA,  total  RNA  was  extracted  from  these  cells  and 
examined by Northern blot analysis using an H-2-specific probe (Fig.  3).  Equal 
amounts  (as  determined  by optical  density and  ethidium  bromide  staining)  of WEIS  AND  MURRE  361 
FIGURE  3.  Northern blot analysis of H-2-specific mRNA in cells transfected with the metal- 
lothioneill-promoted  H-2  hybrid  genes.  Total  RNA  was  extracted  from  DM-I-,  LM-I-, 
MDL-, and pDL-transfected cells and analyzed by Northern  blot hybridization with an H-2- 
specific probe. Equal amounts (5 t~g) of total RNA were loaded per lane. 
total  RNA were loaded into the gel.  All four samples had the same amount of 
/32-microglobulin  mRNA,  as  determined  by  rehybridizing  a  /32-microglobulin- 
specific probe  to  the  same  nitrocellulose  filter.  The  LM-1  cell  contained  the 
greatest amount of H-2-specific mRNA and DM-1 the least. Both MDL and pDL 
cells contained  H-2-specific mRNA  levels below that  of the  LM-1  cell.  Thus, 
mRNA levels alone do not account for the enhanced  expression of the hybrid 
H-2  antigens  (encoded  by the  MDL  and  pDL  genes)  over that  of the  H-2L  d 
antigen. 
Discussion 
The  expression  of the  major  histocompatability  antigens  (H-2  antigens)  is 
constitutive on the surface of most cells of the mature mouse (3). Apparently, H- 
2  expression  occurs soon after  the first steps of cellular  differentiation  of the 
developing mouse embryo, since molecular analysis (20, 21) of murine embryonal 
carcinoma cells demonstrates  the absence of B~-microglobulin and  H-2 mRNA 
in the undifferentiated cell, but the presence of class I antigen complexes on the 
surface of differentiated cells. Additional experiments show that the level of class 
I  antigens  expressed  on  the surface of mature  cells may vary with  the  mouse 
strain or specific cell types examined, or with the effects of external stresses on 
the cells. For example, increased levels of class I antigens on the cell surface are 
apparently important  in the resistance of certain strains of mice to plasmodium 
infections (22), while decreased levels of class I antigens on leukemic T  cells may 
provide these cells with a mechanism to escape from the animal's normal immune 
surveillance  network  (23).  In  addition,  the  level  of major  histocompatability 
antigens  may be altered  by the expression of different class I  antigens,  such as 362  DIFFERENTIAL  EXPRESSION  OF  H-2D d  AND  H-2L e  ANTIGENS 
the TL antigens. Antigenic modulation experiments demonstrate that, when the 
TL antigen is removed from the cell surface, the levels of H-2D increase but the 
surface  levels of H-2K  remain  the  same  (24,  25).  More  recently,  it  has  been 
shown  that  adenovirus  12  infections  apparently  block the  synthesis of class  I 
antigens  in  infected cells (26) and  that  SV-40-transformed  cells may express a 
new TL-Qa-like  transcript  (27).  Thus,  it is important  and  useful to define the 
regulation of class I antigen expression and what factors determine the relative 
amounts of various class I antigens. 
In this paper, we demonstrate that the relative level of expression of two class 
I antigens,  H-2D  e and H-2L  ~, is not dependent on the level of mRNA transcrip- 
tion  or  protein  translation,  but  on  a  particular  domain  of the  molecule.  By 
moving protein domains from the H-2L  d molecule to the H-2D  ~ chain, and vice 
versa, we demonstrated that the enhanced cell surface expression of the H-2D  d 
molecule over the H-2L  ~ antigen is due to the N domain of the H-2D  d antigen. 
The  mechanism  the  cell  uses to  discriminate  between  H-2L  d and  H-2D  e  N 
domains is not clear. A  large degree of heterogeneity of H-2 antigens is found 
in the N domain.  In the wild mouse population, this heterogeneity may provide 
an  immune  response against a  variety of infections (28).  Our data suggest this 
polymorphism may also control the level of different H-2 antigens (H-2K, H-2D, 
and H-2L) on the cell surface. 
Although the level of expression of 32-microglobulin can limit class I antigen 
expression on the cell surface (12, 29, 30), it is unlikely that differential compe- 
tition for the available 32-microgiobulin allows H-2D  ~ molecule expression to be 
higher than  H-2L  d. The N domain presumably does not bind the 32-microglob- 
ulin  chain  (the  C2  domain  is associated with  the  32-microglobulin  chain  after 
tryptic fragmentation  of the mature H-2 chain) (31). Also, both DM-1 and LM- 
1 cells show depressed levels of expression of endogenous H-2 antigens (12) (as 
do MDL, pDL,  37.2.1,  and  37.1.3 cells) (data not shown), indicating that both 
H-2L  ~ and H-2D  e antigens compete well with endogenous H-2 antigens for the 
available 39-microglobulin. Thus, the lower expression of H-2L  d antigen relative 
to H-2D  a antigen  is probably not due to the inability of the  H-2L  ~ antigen  to 
successfully compete for 32-microglobulin. 
Instead,  the enhanced  expression  of H-2D  d antigen  may result  from the  H- 
2D  d N domain determining the number of sites available to that protein molecule 
in the cell membrane (32). As previously noted (12), the amount of endogenous 
H-2 antigens  (H-2K  k and  H-2D  k) is reduced >90%  on the surface of mouse L 
cells into which DM and/or LM plasmids have been introduced (data not shown). 
The introduction  of additional  copies of the mouse 32-microglobulin gene (33) 
into the DM cell line does not significantly alter the amount of H-2D  d on the cell 
surface.  However, cell surface expression  levels of H-2K  k and  H-2D  k antigens 
return  to  those  on  the  surface of control  mouse  L  cells  (Weis and  Seidman, 
unpublished  data).  This  suggests that  H-2D  d antigen  has already occupied all 
sites on the cell surface available to the protein,  and cannot occupy more even 
in the presence of additional 32-microglobulin molecules. Thus, the H-2K  k and 
H-2D  k antigens are able to fill the remaining  sites, since 32-microglobulin is no 
longer  limiting.  These  data,  together  with  the  enhanced  expression  of H-2D  e 
over H-2L  't antigen, suggest the N  domain may determine what sites in the cell WEIS  AND  MURRE  363 
surface membrane are filled by a  particular class I  molecule, i.e., the N  domain 
acts  as  a  recognition  site  for  a  cell  sorting  mechanism.  That  such  a  sorting 
mechanism exists has been previously proposed by Guan and Rose (34), for the 
secretion  of proteins  through  the  cell surface, and  by von  Figura and  Weber 
(35), for the localization of lysosomai hydrolases from the Goigi apparatus into 
primary iysosomes. To fully test whether such an H-2-sorting mechanism exists, 
further study is required, using additional hybrid molecules constructed of H-2 
genes  from  several  other  H-2  hapiotypes.  Analysis  of the  expression  of these 
hybrid genes in  the  mouse L  cell should determine if the  N  domains of other 
class  I  antigens  can  control  the  level  of antigen  expression  or  if the  control 
mechanisms  in  the expression of the  H-2D  d and  H-2L  d antigens are unique to 
those molecules. 
Summary 
To determine why the H-2D  d antigen is expressed on the surface of transfected 
cells at a rate several-fold higher than an analogously transfected H-2L  e molecule, 
we analyzed both previously described and new H-2 hybrid genes. These genes 
were  constructed  by  exchanging  domains  between  H-2  genes.  Quantitative 
radioimmunoassay indicates that the region of the H-2D  ° molecule responsible 
for  its  enhanced  expression  resides  in  the  polymorphic  N  domain,  the  first 
domain of the mature class I molecule. 
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